Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

This publication has 44 references indexed in Scilit:

• Normal and neoplastic urothelial stem cells: getting to the root of the problem
  Nature Reviews Urology, 2012
• p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer
  Cancer Cell, 2012
• Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
  Breast Cancer Research and Treatment, 2011
• Distinct Expression Profiles of p63 Variants during Urothelial Development and Bladder Cancer Progression
  The American Journal of Pathology, 2011
• TRIM24 links a non-canonical histone signature to breast cancer
  Nature, 2010
• Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression
  Urologic Oncology: Seminars and Original Investigations, 2010
• Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells
  Proceedings of the National Academy of Sciences, 2009
• A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery
  Proceedings of the National Academy of Sciences, 2007
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
  Proceedings of the National Academy of Sciences, 2001
• p53 Status and the Efficacy of Cancer Therapy in Vivo
  Science, 1994